{"nct_id":"NCT04862286","title":"Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 6 and 17 Years With Moderate to Severe Plaque Psoriasis Treated With Subcutaneous (SC) Injection of Risankizumab Who Have Completed Participation in Study M19-977","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2021-07-24","start_date_type":"ACTUAL","primary_completion_date":"2028-04","primary_completion_date_type":"ESTIMATED","completion_date":"2028-04","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["ABBV"]}